Ronald Asbury Andrews Precipio, Inc. (PRPO) insider trading activity

Ronald Asbury Andrews is Director of Precipio, Inc.. Currently has a direct ownership of 15,228 shares of PRPO, which is worth approximately $223,242. The most recent transaction as insider was on Jul 16, 2025, when has been sold 676 shares (Common Stock) at a price of $14.78 per share, resulting in proceeds of $9,991. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.2K

4.65% 3M change

58.33% 12M change

Total Value Held $223,242

RONALD ASBURY ANDREWS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 16 2025	BUY Grant, award, or other acquisition	$9,991 $14.78 p/Share	676 Added 4.25%	15,228 Common Stock
Apr 15 2025	BUY Grant, award, or other acquisition	$9,996 $5.6 p/Share	1,785 Added 10.93%	14,552 Common Stock
Jan 15 2025	BUY Grant, award, or other acquisition	$9,997 $6.1 p/Share	1,639 Added 11.38%	12,767 Common Stock
Oct 15 2024	BUY Grant, award, or other acquisition	$9,996 $6.62 p/Share	1,510 Added 11.95%	11,128 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	$9,986 $4.63 p/Share	2,157 Added 18.32%	9,618 Common Stock
Apr 15 2024	BUY Grant, award, or other acquisition	$20,998 $6.66 p/Share	3,153 Added 29.71%	7,461 Common Stock
Oct 24 2023	BUY Grant, award, or other acquisition	-	4,005 Added 48.18%	4,308 Common Stock
Sep 12 2023	BUY Grant, award, or other acquisition	-	6,060 Added 50.0%	6,060 Common Stock

Also insider at

OCX

Oncocyte Corp Healthcare

Former CEO

RAA